Strides Pharma Science

Strides Pharma Science Pre-Tax Margin

The Pre-Tax Profit Margin of Strides Pharma Science (STAR.NS) as of Nov 22, 2026 is 10.67 %. In the previous year, Pre-Tax Profit Margin was -2.95 % — a change of -461.44% (higher).

Pre-Tax Margin

10.67 %

YoY

-461.44%

Last updated:

Pre-Tax Profit Margin of Strides Pharma Science is 2025 10.67 % . Pre-Tax Profit Margin of Strides Pharma Science was 2024 -2.95 % . It decreases by -461.44% higher compared to the previous year.

The Strides Pharma Science Pre-Tax Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Pre-Tax Margin
Date
Pre-Tax Margin
Jan 1, 2018
2.81 INR
Jan 1, 2019
2.86 INR
Jan 1, 2020
1.99 INR
Jan 1, 2021
8.31 INR
Jan 1, 2022
-21.25 INR
Jan 1, 2023
-7.76 INR
Jan 1, 2024
-2.95 INR
Jan 1, 2025
10.67 INR
The Strides Pharma Science Pre-Tax Margin history
YEARPre-Tax MarginYoY
10.67 %-461.44%
-2.95 %-61.97%
-7.76 %-63.49%
-21.25 %-355.88%
8.31 %+317.85%
1.99 %-30.61%
2.86 %+2.00%
2.81 %-77.45%
12.45 %+121.92%
5.61 %-54.85%
12.43 %+81.73%
6.84 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Strides Pharma Science Stock analysis

What does Strides Pharma Science do? Strides Pharma Science Ltd. generates revenue through the development, manufacturing, and distribution of IP-led generics and bio-pharmaceutical products across its Pharmaceutical and Bio-pharmaceutical segments. The company serves global markets including Africa, Australia, Asia (excluding India), North America, Europe, India, and Others, offering niche pharmaceutical products in various dosage forms such as liquids, creams, ointments, soft gels, sachets, tablets, and modified release formats. Its manufacturing units in Bengaluru, Puducherry, Chennai, Singapore, Milan, Florida, and Nairobi produce anti-retroviral, anti-malarial, anti-tuberculosis, hepatitis, and other infectious disease drugs, alongside soft gelatin capsules. The firm's revenue streams are derived from the sale of its IP-led niche pharmaceutical products to healthcare providers, distributors, and global pharmaceutical companies operating in the specified geographical segments. Key product categories include anti-retroviral, anti-malarial, anti-tuberculosis, and hepatitis treatments, which are distributed through its global manufacturing network. The company's focus on specialized drug segments ensures consistent demand from healthcare systems and institutions managing infectious diseases. Strides Pharma Science Ltd. targets healthcare institutions, distributors, and pharmaceutical companies in regions such as North America, Europe, India, and Africa, where infectious disease management requires specialized treatments. Its manufacturing presence in multiple countries supports direct market access and cost efficiency, enabling the delivery of affordable pharmaceutical solutions. The company's product portfolio emphasizes high-demand therapeutic areas, aligning with global health priorities for infectious disease treatment. Strides Pharma Science is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Strides Pharma Science stock

Pre-Tax Profit Margin of Strides Pharma Science is 10.67 % in 2025.

Pre-Tax Profit Margin of Strides Pharma Science changed from -2.95 % to 10.67 %, representing a -461.44% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Pre-Tax Profit Margin Strides Pharma Science since 2006 – with annual values, charts, and detailed analysis.

Pre-tax margin measures the percentage of revenue remaining after all expenses except income taxes. It isolates operational and financial performance from tax effects.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Pre-Tax Profit Margin's Strides Pharma Science with sector peers and the industry average to assess whether it is attractive.

To evaluate Pre-Tax Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Pre-Tax Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Strides Pharma Science

All Key Metrics — Strides Pharma Science